KURA Archives - Blue Horseshoe Stocks

A Terrific Tuesday, FIVE Fresh Ideas

Tuesday’s Big Runners:

The flow of big name earnings reporters returned yesterday, and with it came three potential options trading ideas for our premarket report. Thanks in part to another strong day for the markets, all three of those plays could have worked in traders’ favor in a big way. We have another huge earnings load being dumped for today, so we would expect to see this exciting activity persist as we cruise through this midweek.

Yesterday’s earnings-related runners were the RTX Weekly $87-88 Calls, the UAL Weekly $39.50-40.50 Calls, and the GE Weekly $130-129 Puts, and they exhibited the following intraday moves on the session:

RTX Weekly $87-88 Calls
$87: 1.65-5.35 (+224%)
$88: 1.04-4.40 (+323%)
_____

UAL Weekly $39.50-40.50 Calls
$39.50: .88-2.30 (+185%)
$40: .63-1.85 (+194%)
$40.50: .43-1.44 (+235%)
_____

GE Weekly $130-129 Puts
$130: .75-1.90 (+153%)
$129: .46-1.30 (+183%)
_____

Once again, the SAVE Calls we’ve been tracking since last Wednesday. registered new highs for us. We called a heck of a bottom play on these targets, and they’ve rewarded us with continued gains over the past week as a result. Below are the total increases we’ve seen in these over that span.

SAVE 02/16 $5.00-7.50 Calls
$5.00: .68-4.35 (+540%)
$7.50: .25-2.50 (+900%)

Fresh Options Ideas:
ASML Weekly $820-830 Calls
NFLX Weekly $540-545 Calls
ISRG Weekly $385-390 Calls
T Weekly $17-16.50 Puts
SAP 02/16 $175-180 Calls

Extended Watchlist:
ABQQ, EBET, BIOF, KGKG, MYSN, GETR, NXU, VSME, RDHL, KURA,

Blue Horseshoe Stocks: EXCLUSIVE AMPG INTERVIEW

AmpliTech Group, Inc. AMPG

We’ve been keeping track of AMPG for ten weeks now, and not only did the stock make a run from .043 to .084 during that time, but it has managed to hold more than half of those gains upon consolidation, and has held firm in the .065-.075 area.

For a company that, for the time being, is rather small in size, AmpliTech has serviced some big accounts in both the government and private sectors. The company’s RF signal amplifiers are top of the line in terms of noise reduction effectiveness, and AMPG exhibited its wares at a recent high profile conference.

We were pleased to attend the 2019 International Microwave Symposium in Boston, Massachusetts last week, where we got the opportunity to sit down and conduct a face-to-face interview with Fawad Maqbool, the CEO of AmpliTech. We highly recommend that you take a few moments to check it out.

VIEW AMPG INTERVIEW NOW!

RH, Inc. RH – Recap

Our bearish options trading idea from yesterday’s report turned out to be our bigger winner for the day. We selected the RH Weekly $120-118 Puts even after the company posted a solid beat on Q1 earnings and raised guidance.

It might have seemed like a counter-intuitive choice to some, but we had good reason. The stock was gapping up way too high in the premarket. We predicted that it would fall after the open, and it turned out to be the right hunch.

The following intraday gains were made possible by our idea:

RH Weekly $120-118 Puts
$120 Puts: 3.80-8.40 (+121%)
$119 Puts: 3.90-6.75 (+73%)
$118 Puts: 3.00-6.29 (+110%)

____

Fresh Options Idea:
AVGO Weekly $252.50-257.50 Calls

Important: DO NOT attempt to trade options contracts with a weekly expiration on a Friday unless you are an advanced level trader with access to disposable funds.

Extended Watchlist:
NVCN, NAKD, HUSA, ARQL, KURA, IGC, LGCY, FVPR

Blue Horseshoe Stocks: NLNK Recap & More

NewLink Genetics Corp. NLNK

After our call of NLNK Thursday morning, the stock traded from 9.50-14.48 (+52%) which was a fantastic move for something it that price range. We noted the strong close, and Friday morning re-iterated our interest despite the big move we’d already witnessed.

It’s a good thing we left NLNK on our radars, because while it didn’t quite rise to the previous session’s intraday performance, it came awfully close, and completed a very nice two-day swing for us in the process. Friday’s trading range on NLNK ran from 13.51 up to a new high of 19.30 for a daily move of 43% and representing a two-session rise of 103%

The stock traded thirteen times its monthly average volume, and maintained well over half its advance into a second consecutive strong close, so we’re quite curious to monitor its activity as we kick off a fresh trading week.

Kura Oncology Inc. KURA

Speaking of higher-priced movers, we also tagged KURA in Friday’s premarket report after the company’s mid-stage cancer treatment trials yielded positive results. It too went on a run which was uncharacteristically volatile for a $9+ stock.

The tradin grange on this one ran from 9.30-13.80 for an intraday push of 48% and did so on over 20X the monthly average volume. The close wasn’t quite as strong as the previously mentioned play, but we’ll still leave a slot open on our radar screens for KURA heading into this week.

______

Honorable Mention: Adaptimmune Therapeutics plc ADAP – While the level of gains provided wasn’t quite as high following our tag of ADAP on Thursday, the stock did string together a noteworthy couple of sessions. It traded from a low of 7.02 on Thursday to a high of 8.95 on Friday, marking a 27% swing.

Extended Watchlist:
MRNS, TEVA, BSMX, LINU, PETS

Blue Horseshoe Stocks: Options, NLNK Recaps & More

GoPro, Inc. GPRO

We took advantage of the situation with GPRO yesterday after noticing the stock light up the boards in the premarket on the heels of a guidance adjustment.

We set our sights on the GPRO Weekly $9.50 & $10 Calls and both sets of contracts ended up providing traders with a chance at notable intraday gains.

The $9.50’s ran from .13-.90 for a whopping intraday pop of 592%, while the $10’s traded in a range from .47-1.20 for chances at up to 155% profit.

Insmed, Inc. INSM – Update

We’ve also got the pleasure of updating the figures on the options idea we put out on Tuesday after INSM had yet another solid session. The updated ranges on the contracts we selected are quite impressive, including a twelve-bagger, clearly demonstrating why we devote so much energy to options trading in addition to stocks!

The gains that were up for grabs to anyone who was paying attention were as follows:

$27 Calls – Range: .95-4.50 – Max Gain: 373%
$28 Calls – Range: .25-3.40 – Max Gain: 1260%
$29 Calls – Range: .40-2.75 – Max Gain: 588%
$30 Calls – Range: .50-2.12 – Max Gain: 324%

NewLink Genetics Corp. NLNK

We also had some very good fortune with our call of NLNK yesterday morning, which we caught notice of on our routine morning scan after some abnormal activity cropped up in the premarket.

Despite the fact that it went into the session as a $9+ stock, we still saw a really nice intraday push en route to NLNK going on the books as the NASDAQ’s top mover. We observed as the stock ran from a low of 9.50, traded up for essentially the entire session, and hit a high of 14.48 for a hefty 52% move on the day.

NLNK closed with strength, maintaining well over half its daily advance, so we’ll definitely want to continue to monitor the situation. No matter how you slice it, a single-session gain of 50% from a nearly ten-dollar stock, is nothing short of incredible.

Extended Watchlist:
CLDR, KURA, AVEO, OPGN, EPIX, FUTL,
FRTA(Bottom-Bouncer)

Blue Horseshoe Stocks: Updates, Fresh Plays & More

Kraig Biocraft Laboratories, Inc. KBLB

We alerted KBLB in Wednesday morning’s premarket report, and on that day, we would observe a PPS low of .0261. Yesterday, the stock hit a high of .0395, for a respectable two-session upswing of 51%

Following that solid run-up, we saw the stock close at .0375, maintaining a vast majority of its advance. We’ll continue to keep a steady eye on KBLB, and look for it to maintain support above the .03-mark in order to keep us interested.

Potential Bottom-Plays

Rennova Health, Inc. RNVA – We have an interesting story unfolding with RNVA, and a potential rebound opportunity as well. After briefly cracking its 50DMA on Wednesday, the stock took a major gut punch yesterday as it gapped down immensely.

It seems a bit of an overreaction after reading the PR that apparently catalyzed the selloff. The company announced yesterday that it had priced a public offering with the intent of raising upwards of $8.6M in capital, expected to close by Tuesday. They set the purchase price at .45, which is why a massive slide to less than .30 seemed disproportionate.

We’ll be interested to see the activity in this now majorly-oversold stock in sessions to come.

__________

Ampio Pharmaceuticals, Inc. AMPE – Speaking of stocks that have recently gapped down hard and found new lows, we have AMPE hitting our bottom-play radar.

Similar to the aforementioned play, the selloff occurred as a result of what some might construe as over-reactive. The company released data from a clinical study at the end of last month on its osteoarthritis injection treatment that was poorly-received. However, while the primary endpoints of the double-blind study were not met, the treatment was markedly effective in improving the patients with the most extreme cases of the condition.

So the study was not a total loss, and the company made clear its intent to submit an FDA application for the treatment for those severely afflicted patients that were helped, and for whom no other non-surgical alternative exists.

That’s why we’ll be keeping an eye on AMPE to continue to regain some of its lost ground, as it has done over the past few sessions.

Extended Watchlist:
MAXD, MFST, PPHM, FES, SPU, KURA, COSI(Bottom watch)